Author:
Ammerpohl O,Trauzold A,Schniewind B,Griep U,Pilarsky C,Grutzmann R,Saeger H-D,Janssen O,Sipos B,Kloppel G,Kalthoff H
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Ammerpohl O, Thormeyer D, Khan Z, Appelskog IB, Gojkovic Z, Almqvist PM, Ekstrom TJ (2004) HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells. Biochem Biophys Res Commun 324: 8–14
2. Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR, Schafer H (2003) Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22: 3243–3251
3. Asklund T, Appelskog IB, Ammerpohl O, Ekstrom TJ, Almqvist PM (2004) Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells. Eur J Cancer 40: 1073–1081
4. Bar-Ner M, Thibault A, Tsokos M, Magrath IT, Samid D (1999) Phenylbutyrate induces cell differentiation and modulates Epstein–Barr virus gene expression in Burkitt's lymphoma cells. Clin Cancer Res 5: 1509–1516
5. Bengala C, Guarneri V, Giovannetti E, Lencioni M, Fontana E, Mey V, Fontana A, Boggi U, Del Chiaro M, Danesi R, Ricci S, Mosca F, Del Tacca M, Conte PF (2005) Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma. Br J Cancer 93: 35–40
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献